Bio
Dr Louise Emmett is the Director of Theranostics and Nuclear Medicine at St Vincent’s Hospital, Sydney, and a clinical researcher at the Garvan Institute of Medical Research. She is a Professor of Medicine (conjoint) at the University of New South Wales.
Dr Emmett underwent her medical training at Auckland University, New Zealand, physician training in Sydney, Australia, and post-graduate training in nuclear cardiology in Toronto, Canada. Her Doctorate of Medicine in nuclear cardiology was completed based on weight of publications in 2014.
Dr Emmett has a subspecialty interest in prostate cancer, and since 2014, she has commenced and contributed to multiple imaging and therapy trials in prostate cancer using PSMA PET and PSMA-targeted therapy. This includes acting as Principal Investigator (or Co-PI) on multiple prospective phase 1-3 imaging and therapy theranostics trials.
Dr Emmett’s research focuses on the clinical development of new theranostic agents, optimal combinations, and functional imaging biomarkers for better personalisation of treatment choices in theranostics.
